Cardiovascular

The rising cost of code stroke imaging and treatment: A six-year experience at a primary stroke center.

TL;DR

Annual Code Stroke imaging expenditures rose nearly three-fold over six years while the number of patients receiving reperfusion therapy remained stable, resulting in a more than four-fold increase in average imaging cost per treated patient.

Key Findings

Annual Code Stroke activations nearly tripled from 2020 to 2025 at a single primary stroke center.

  • Annual activations rose from 133 cases in 2020 to 298 cases in 2025.
  • This represents an approximately three-fold increase over the six-year study period.
  • The study was a six-year retrospective analysis of all Code Stroke activations at one institution.
  • Data were collected from 2020 through 2025.

CTA head and neck utilization increased approximately 800% over the study period.

  • The approximately 800% increase in CTA head and neck utilization was identified as the primary driver of rising imaging expenditures.
  • The study tracked initial neuroimaging modality ordered for each Code Stroke activation.
  • Trends in cumulative radiation exposure were also evaluated alongside imaging cost and modality data.

Annual imaging expenditure increased nearly four-fold from 2020 to 2025.

  • Annual imaging expenditure rose from $70,616 in 2020 to $259,290 in 2025.
  • This represents an increase of approximately $188,674 per year over the study period.
  • The analysis evaluated trends in estimated total imaging cost across all Code Stroke activations.

The number of patients receiving intravenous thrombolysis (IVT) or endovascular thrombectomy (EVT) remained stable despite the large increase in Code Stroke activations.

  • 19 cases received IVT or EVT in 2020 compared to 16 cases in 2025.
  • Treatment yield declined from 14.3% in 2020 to 5.4% in 2025.
  • A treated Code Stroke patient was defined as a case resulting in IVT or EVT treatment.
  • The proportion of Code Strokes resulting in reperfusion decreased over the entire study period.

The average imaging cost per treated Code Stroke patient increased more than four-fold over the study period.

  • Average cost per treated patient rose from $3,717 in 2020 to $16,205 in 2025.
  • This represents a greater than four-fold increase in per-treated-patient imaging cost.
  • The authors characterize this as 'a disproportionate rise in imaging utilization and cost relative to the number of treated Code Strokes.'

The study was motivated by the hypothesis that increasing imaging expenditures would correspond to higher rates of reperfusion therapy following expanded IVT and EVT guideline indications.

  • The authors noted that increasing cost of acute stroke evaluation has been well documented prior to this study.
  • Published guidelines have expanded the use of both intravenous thrombolysis and endovascular thrombectomy.
  • The study design was a six-year retrospective analysis at a primary stroke center.
  • The hypothesis was not supported, as reperfusion therapy rates did not rise proportionally with imaging utilization.

What This Means

This research suggests that hospitals are spending dramatically more money on brain imaging for suspected stroke patients, but this increased spending has not translated into more patients actually receiving stroke treatment. At one hospital over six years, the number of 'Code Stroke' emergency activations nearly tripled and the annual imaging bill grew from about $70,000 to nearly $260,000, largely because CT scans of the head and neck became used far more frequently. However, the number of patients who ended up receiving clot-dissolving drugs or procedures to remove blockages stayed roughly the same — about 16 to 19 patients per year. As a result, the cost of identifying each patient who actually needed and received treatment skyrocketed. In 2020, it cost on average about $3,700 in imaging to find and treat one stroke patient; by 2025, that figure had climbed to over $16,000. The treatment rate among all Code Stroke patients dropped from 14.3% to just 5.4%, meaning that by 2025, fewer than 1 in 18 patients triggered for emergency stroke evaluation actually received reperfusion therapy. These findings matter because they highlight a potential inefficiency in how emergency stroke protocols are being applied. While broader use of advanced imaging and stroke alerts can help catch more treatable strokes, this study suggests that the net of who gets a Code Stroke activated has widened considerably without a corresponding increase in patients benefiting from treatment. This raises questions about how stroke protocols should be designed and how resources can be allocated more efficiently in emergency stroke care.

Have a question about this study?

Citation

Parikh N, Glick Y, Bryson A, Williams-Square D, Lu S. (2026). The rising cost of code stroke imaging and treatment: A six-year experience at a primary stroke center.. Clinical imaging. https://doi.org/10.1016/j.clinimag.2026.110936